Simplex Trading
DTIL icon

Simplex Trading’s Precision BioSciences DTIL Stock Holding History

Simplex Trading’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.3K Buy
3,512
+99
+3% +$457 ﹤0.01% 6809
2025
Q4 		$14.2K Buy
+3,413
New +$19.4K ﹤0.01% 6759
2024
Q1 		– Sell
-3
Closed – – 9051
2023
Q4 		$0 Hold
3
– – ﹤0.01% 9008
2023
Q3 		$0 Buy
+3
New +$46 ﹤0.01% 8900
2023
Q1 		– Sell
-509
Closed -$16.8K – 9251
2022
Q4 		$18K Sell
509
-283
-36% -$11.2K ﹤0.01% 6969
2022
Q3 		$30K Buy
792
+252
+47% +$12K ﹤0.01% 7070
2022
Q2 		$25K Buy
540
+438
+429% +$25.7K ﹤0.01% 7323
2022
Q1 		$9K Buy
102
+83
+437% +$11.3K ﹤0.01% 8950
2021
Q4 		$4K Sell
19
-164
-90% -$45.8K ﹤0.01% 9660
2021
Q3 		$69K Hold
183
– – ﹤0.01% 7099
2021
Q2 		$68K Buy
183
+15
+9% +$4.5K ﹤0.01% 7250
2021
Q1 		$52K Sell
168
-701
-81% -$245K ﹤0.01% 6562
2020
Q4 		$0 Buy
+869
New +$213K ﹤0.01% 8485
2020
Q2 		– Sell
-84
Closed -$18.4K – 7745
2020
Q1 		$15K Buy
+84
New +$22K ﹤0.01% 6170

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Simplex Trading's DTIL Position: Q1 2026 in Review

Simplex Trading increased its Precision BioSciences (DTIL) stake by 2.9% in Q1 2026, buying an estimated $457 and bringing the position to 3,512 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6809.

Simplex Trading first reported a position in DTIL in Q1 2020 and has held it in 14 quarters since. The position peaked at $69K in Q3 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Simplex Trading held 3,512 shares of Precision BioSciences worth $19.3K as of Q1 2026.
  • Simplex Trading bought 99 Precision BioSciences shares in Q1 2026, an estimated $457.
  • Precision BioSciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6809 holding.
  • Simplex Trading first reported a position in Precision BioSciences in Q1 2020 and has held it in 14 quarters since.
  • Simplex Trading's Precision BioSciences position peaked at $69K in Q3 2021.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.